drugset / Trial / NCT03406338

Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease

NCT03406338

Phase 4 Active not recruiting 60 enrolled Region Skane
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial will compare the outcome of surgery (fasciectomy) with that of local injection of Collagenase Clostridium Histolyticum in patients with recurrent finger joint contracture after previous treatment with Surgery, collagenase injection or needle fasciotomy. Half of the participants will be treated with surgery while the other half will receive collagenase injection.

Timeline

Start
2018-03-20
Primary completion
2024-09-01
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Collagenase Clostridium Histolyticum Protein / enzyme biologic 0.8 mg Other

Indications